Financhill
Sell
21

HEPA Quote, Financials, Valuation and Earnings

Last price:
$0.06
Seasonality move :
-9.8%
Day range:
$0.05 - $0.07
52-week range:
$0.05 - $68.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.30x
Volume:
49.7K
Avg. volume:
2.3M
1-year change:
-99.9%
Market cap:
$658.6K
Revenue:
--
EPS (TTM):
-$80.50

Earnings Data

Next earnings date for HEPA
Aug 13
2025
Most recent earnings per share
-$2.15
Missed by $2.15
(May 19/2025)
Consensus Estimate
--
(May 19/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

HEPA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/19/2025 Q1 -- -- -$2.15 -- --
12/31/2024 Q4 -- -- -$8.35 -- --
11/14/2024 Q3 -- -- -$36.00 -- --
08/13/2024 Q2 -- -- -$34.00 -- --
05/21/2024 Q1 -- -- -$28.13 -- --
12/31/2023 Q4 -- -- -$121.07 -$131.50 $10.43
11/20/2023 Q3 -- -- -$137.00 -$156.00 $19.00
08/14/2023 Q2 -- -- -$184.00 -$166.17 -$17.83
05/12/2023 Q1 -- -- -$174.00 -$180.00 $6.00
12/31/2022 Q4 -- -- -$131.00 -$130.00 -$1.00
11/14/2022 Q3 -- -- -$112.00 -$170.00 $58.00
08/15/2022 Q2 -- -- -$261.00 -$120.00 -$141.00
05/16/2022 Q1 -- -- -$91.00 -$130.00 $39.00
12/31/2021 Q4 -- -- -$130.00 -- --
11/15/2021 Q3 -- -- -$120.00 -- --
08/16/2021 Q2 -- -- -$100.00 -- --
05/14/2021 Q1 -- -- -$120.00 -- --
03/25/2021 Q4 -- -- -$154.74 -- --
11/16/2020 Q3 -- -- -$690.00 -- --
08/12/2020 Q2 -- -- -$580.00 -- --
03/31/2020 Q1 -- -- -$970.00 -- --
12/31/2019 Q4 -- -- -$588.08 -- --
09/30/2019 Q3 -- -- -$530.00 -- --
06/30/2019 Q2 -- -- -$1,863.00 -- --
03/31/2019 Q1 -- -- -$6,761.05 -- --
12/31/2018 Q4 -- -- -$9,361.67 -- --
09/30/2018 Q3 -- -- -$38,467.24 -- --
06/30/2018 Q2 -- -- -$26,507.07 -- --
03/31/2018 Q1 -- -- -$17,817.80 -- --
12/31/2017 Q4 -- -- -$18.65 -$44.80 $26.15
09/30/2017 Q3 -- -- -$41,540.83 -- --
06/30/2017 Q2 -- -- -$4,800.41 -- --
03/31/2017 Q1 -- -- -$67,421.47 -- --
12/31/2016 Q4 -- -- -$40,227.56 -- --
09/30/2016 Q3 -- -- -$48,655.53 -- --
06/30/2016 Q2 -- -- -$91,338.05 -- --
03/31/2016 Q1 -- -- -$81,614.44 -- --
12/31/2015 Q4 -- -- -$63,134.04 -- --
09/30/2015 Q3 -- -- -$124,216.46 -- --
06/30/2015 Q2 -- -- -$137,825.67 -- --

Hepion Pharmaceuticals Earnings Questions

  • How Much did Hepion Pharmaceuticals Generate in Revenue Last Quarter?

    Hepion Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Hepion Pharmaceuticals Beat Earnings Last Quarter?

    Hepion Pharmaceuticals announced earnings per share of -$2.15 which represents a miss of analyst forecast a -- per share.

  • Is Hepion Pharmaceuticals Profitable?

    Hepion Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Hepion Pharmaceuticals EPS Next Year?

    Hepion Pharmaceuticals's earnings are forecast to decrease from -$107.35 per share to -$11.43 per share next year representing a decrease of -98.15%.

  • When is Hepion Pharmaceuticals's Earnings Date?

    Hepion Pharmaceuticals's next earnings date is August 13, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Dell Stock Be in 5 Years?
Where Will Dell Stock Be in 5 Years?

So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…

Where Will Cameco Stock Be in 5 Years?
Where Will Cameco Stock Be in 5 Years?

Cameco (NYSE: CCJ) isn’t exactly the kind of stock you…

Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth
Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth

Microsoft (NASDAQ:MSFT) has been among the top growth stocks of…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
70
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 47x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
84
SBET alert for May 30

SharpLink Gaming [SBET] is down 9.1% over the past day.

Buy
55
RGC alert for May 30

Regencell Bioscience Holdings [RGC] is up 11.14% over the past day.

Buy
73
CTEV alert for May 30

Claritev [CTEV] is up 6.57% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock